Picard Medical (PMI) Interest & Investment Income (2024 - 2026)

Picard Medical (PMI) has reported Interest & Investment Income for 3 consecutive years, with -$89000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest & Investment Income rose 96.33% year-over-year to -$89000.0; the trailing twelve-month figure through Jun 2026 stood at -$2.5 million (up 56.77% YoY), and the FY2025 full-year result was -$5.4 million, down 75.84% from the prior year.
• Interest & Investment Income declined to -$89000.0 in Q2 2026 per PMI's latest filing, from -$5000.0 in the prior quarter.
• Across five years, Interest & Investment Income topped out at -$5000.0 in Q1 2026 and bottomed at -$2.4 million in Q2 2025.
• Historically, Interest & Investment Income has averaged -$1.0 million across 3 years, with a median of -$968500.0 in 2024.
• The widest YoY moves for Interest & Investment Income: up 99.51% in 2025, down 73.95% in 2025.
• Over 3 years, Interest & Investment Income stood at -$1.4 million in 2024, then jumped by 99.51% to -$7000.0 in 2025, then plunged by 1171.43% to -$89000.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered -$89000.0, -$5000.0, and -$7000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.